COVID-19 pandemic causes cervical cancer screening crisis
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Cervical cancer screening programmes—which are already scarce in low-income and middle-income countries—have been devastated by the double blow of COVID-19 and UK foreign aid cuts, according to experts in global gynaecological health.
Despite being preventable and curable with early detection and treatment, cervical cancer remains the fourth most common cancer type globally among women and one of the most deadly, responsible for killing more than 300 000 women in 2018, according to WHO. The majority (85%) of these deaths occurred in low-income and middle-income countries, where access to public health services is limited, and where screening and treatment programmes for the disease have not been widely implemented.
The Lancet Oncology , commentaire en libre accès, 2020